Biography and Research Information
OverviewAI-generated summary
Jackson Hoesley's research focuses on the prognostic significance of biomarkers and the diagnostic performance of functional assays. His work has investigated the neutrophil-to-lymphocyte ratio as a prognostic indicator in small cell lung cancer, particularly in the context of immunotherapy treatment. Additionally, Hoesley has examined the real-world performance of assays used in the diagnosis of Heparin-Induced Thrombocytopenia (HIT), including the PF4-dependent P-Selectin Expression Assay (PEA) and the Serotonin Release Assay (SRA). These studies contribute to understanding diagnostic tool effectiveness and patient outcome prediction in clinical settings. Hoesley collaborates with researchers at the University of Arkansas for Medical Sciences, including Jacob T. Wooldridge, Konstantinos Arnaoutakis, and Bhavesh Mohan Lal.
Metrics
- Publications: 3
Selected Publications
-
Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy. (2025)
-
The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT) (2024)
Collaboration Network
Top Collaborators
Rance C. Siniard
University of Alabama at Birmingham (US)
2 shared publications
- Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Laura Taylor
University of Alabama at Birmingham (US)
2 shared publications
- Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Cari E. Reed
University of Alabama at Birmingham (US)
2 shared publications
- Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Marisa B. Marques
University of Alabama at Birmingham (US)
2 shared publications
- Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Jori E. May
University of Alabama at Birmingham (US)
2 shared publications
- Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Joud El Dick
University of Alabama at Birmingham (US)
1 shared publication
- The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Bhavesh Mohan Lal
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
Navin Kumar
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
Jacob T. Wooldridge
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
Konstantinos Arnaoutakis
1 shared publication
In database
- Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy.
Similar Researchers
Based on overlapping research topics
Ples Spradley
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Health and Medical Research Impacts
Shoon Oo
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Genomics and Diagnostics
Health and Medical Research Impacts
R. L. Stone
University of Arkansas – Fort Smith
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Health and Medical Research Impacts
Ruud Dings
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Health and Medical Research Impacts
Mazin Safar
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Health and Medical Research Impacts
Brad Baltz
University of Arkansas – Fort Smith
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Health and Medical Research Impacts